DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Geissbühler YBH, Hernández-Diaz S et al.
Pregnancy outcomes from fingolimod clinical trials and post-marketing experience and the need for a multinational Gilenya™ (fingolimod) Pregnancy Exposure Registry in Multiple Sclerosis.
Lyon, France:
ECTRIMS; 2012 12 Oct; Abstract 751
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.